SCHEMBL196320

SCHEMBL196320

F[CH]Oc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28616418 0.78 LTA4H (0.41)
SCHEMBL16782647 0.75 LTA4H (0.50)
SCHEMBL2818335 0.75 LTA4H (0.50)
SCHEMBL2818333 0.75 LTA4H (0.50)
SCHEMBL6606014 0.75 LTA4H (0.50)
SCHEMBL28369275 0.73 LTA4H (0.47)
SCHEMBL5274339 0.72 LTA4H (0.41)
SCHEMBL3866432 0.72 LTA4H (0.41)
SCHEMBL10910725 0.71 ACHE (0.56)
SCHEMBL4959168 0.71 CA1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107344940-B BTK inhibitors and uses thereof 广东东阳光药业有限公司 2020-04-21 CN claimed
CN-102264693-B The acrylamide derivative of inhibitor is changed as mitochondrial permeability CONGENIA S.R.L. (IT) 2016-01-27 CN claimed
CN-102858743-B Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes HOFFMANN LA ROCHE 2015-06-10 CN claimed
US-8633206-B2 Pyrrolo[2,3-D]pyrimidine compounds PFIZER INC. (US) 2014-01-21 US claimed
CN-101600700-B Novel 2-amino oxazolines as TAAR1 ligands for CNS disorders HOFFMANN LA ROCHE 2013-08-21 CN claimed
EP-2488524-B1 PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS PFIZER (US) 2013-07-03 EP claimed
CN-102112447-B HIV integrase inhibitors from pyridoxine AMBRILIA BIOPHARMA INC 2013-06-26 CN claimed
US-8344018-B2 Oxindolyl inhibitor compounds GILEAD SCIENCES, INC. (US) 2013-01-01 US claimed
EP-2488524-A1 PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS Pfizer Inc. (US) 2012-08-22 EP claimed
CN-101243050-B Pyrazolone derivatives HOFFMANN LA ROCHE 2012-07-04 CN claimed
EP-2091926-A1 SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS Novartis AG (CH) 2009-08-26 EP claimed
US-20090005374-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD SCIENCES, INC. 2009-01-01 US claimed
WO-2009002534-A1 IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS GILEAD COLORADO, INC. (US) 2008-12-31 WO claimed
CN-101243050-A Pyrazolone derivatives HOFFMANN LA ROCHE (CH) 2008-08-13 CN claimed
WO-2008063912-A1 SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS NOVARTIS AG (CH) 2008-05-29 WO claimed
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes F. HOFFMANN-LA ROCHE AG (CH) 2007-03-01 US claimed
EP-0186043-B1 MILBEMYCIN DERIVATIVES WITH PESTICIDE PROPERTIES CIBA-GEIGY AG (CH) 1991-06-19 EP claimed
US-4897416-A 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES CIBA-GEIGY CORPORATION (US) 1990-01-30 US claimed
EP-0279783-A1 Insecticides and parasiticides CIBA-GEIGY AG (CH) 1988-08-24 EP claimed
EP-0186043-A1 Milbemycin derivatives with pesticide properties CIBA-GEIGY AG (CH) 1986-07-02 EP claimed